Improving Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection
Objectives and Disclosures
Participants will be able to:
- Examine the epidemiology of STEC infection and HUS risk in children.
- Interpret the available literature regarding different treatment approaches and clinical outcomes in children with STEC infection.
- Compare treatment approaches in a multicenter prospective study aimed at improving kidney outcomes in children with STEC infection at risk for HUS.
Planners and speaker disclose they have no relevant financial relationships.
Ron Kaplan, MD
Associate Professor of Pediatrics, UW; Emergency Medicine, Seattle Children’s
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.